Kessler L, Jesser C, Lombard Y, Karsten V, Belcourt A, Pinget M, Poindron P
Jeune Equipe Médicale Universitaire, Strasbourg, France.
J Leukoc Biol. 1996 Dec;60(6):729-36. doi: 10.1002/jlb.60.6.729.
The aim of this work was to study in vivo and in vitro the involvement of macrophages and interleukin-1beta (IL-1beta) in the necrosis of encapsulated islets during xenograft and to evaluate the immunoprotective efficiency of the AN69 membrane. In vivo, 6 days after implantation, 65% of the membrane surface of the devices containing the islets was colonized with macrophages compared with only 5% of the surface of the empty control devices. The morphological aspect of implanted islets was altered and their insulin release decreased significantly compared with freshly isolated ones (265 +/- 50 vs. 507 +/- 81 microU/mL). In vitro, the insulin release of encapsulated islets cultured for 2 days decreased to 32 and 28%, respectively, in the presence of IL-1beta and macrophages. The addition of anti-IL-1beta antibody to the co-culture of macrophages and islets did not modify this loss of functional activity. Furthermore, IL-1beta passed through the AN69 membrane. In conclusion, macrophages are involved in damaging encapsulated pancreatic islets and are probably partly responsible for islet transplantation failure.
本研究旨在体内和体外研究巨噬细胞和白细胞介素-1β(IL-1β)在异种移植过程中对包被胰岛坏死的影响,并评估AN69膜的免疫保护效率。在体内,植入6天后,含有胰岛的装置膜表面65%被巨噬细胞定植,而空对照装置表面只有5%被巨噬细胞定植。与新鲜分离的胰岛相比,植入胰岛的形态发生改变,胰岛素释放显著减少(265±50对507±81微单位/毫升)。在体外,在IL-1β和巨噬细胞存在的情况下,培养2天的包被胰岛的胰岛素释放分别降至32%和28%。向巨噬细胞和胰岛的共培养物中添加抗IL-1β抗体并未改变这种功能活性的丧失。此外,IL-1β可穿过AN69膜。总之,巨噬细胞参与破坏包被的胰岛,可能是胰岛移植失败的部分原因。